MCRM
PFE icon

Midway Capital Research & Management’s Pfizer PFE Stock Holding History

Midway Capital Research & Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
50,390
+494
+1% +$12.9K 0.96% 33
2026
Q1 		$1.4M Buy
49,896
+1,586
+3% +$42.2K 1.32% 29
2025
Q4 		$1.2M Buy
+48,310
New +$1.22M 1.17% 30

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Midway Capital Research & Management's PFE Position: Q2 2026 in Review

Midway Capital Research & Management increased its Pfizer (PFE) stake by 0.99% in Q2 2026, buying an estimated $12.9K and bringing the position to 50,390 shares worth $1.21M. The position accounts for 0.96% of the portfolio, ranked #33.

Midway Capital Research & Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.4M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Midway Capital Research & Management held 50,390 shares of Pfizer worth $1.21M as of Q2 2026.
  • Midway Capital Research & Management bought 494 Pfizer shares in Q2 2026, an estimated $12.9K.
  • Pfizer made up 0.96% of Midway Capital Research & Management's portfolio in Q2 2026, its #33 holding.
  • Midway Capital Research & Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Midway Capital Research & Management's Pfizer position peaked at $1.4M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Midway Capital Research & Management's 13F filing for Q2 2026, filed 14 Jul 2026.